<b><img class="alignright size-medium wp-image-201" alt="1512600_512506188857355_564263846_n" src="http://www.southcountyurological.com/wp-content/uploads/2014/05/1512600_512506188857355_564263846_n-300x183.jpg" width="300" height="183" />Ipecac Syrup Shows Promise As A New Chemo Drug </b>

Ipecac syrup, an erstwhile staple found in many families’ medicine cabinets, shows promise as a new chemotherapy drug for bladder cancer, according to a study conducted by Loyola University Medical Center near Chicago.

The study found that emetine dihydrochloride, an active ingredient in <em>ipecac</em><i> </i>syrup, used alone or used with a standard chemotherapy drug called cisplatin, inhibited the proliferation of bladder <em>tumor cells. The study also discovered that emetine has little effect on normal cells. </em>

<em>The study was published online in The Journal of Urology</em><em>.</em>

<em>Years ago, ipecac was used to induce vomiting after ingesting a poison. That practice is no longer recommended. </em>